Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

Cherie T. Ng, J. Pablo Jaworski, Pushpa Jayaraman, William F. Sutton, Patrick Delio, Larene Kuller, David Anderson, Gary Landucci, Barbra A. Richardson, Dennis R. Burton, Donald N. Forthal, Nancy Haigwood

    Research output: Contribution to journalArticle

    102 Citations (Scopus)

    Abstract

    Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.

    Original languageEnglish (US)
    Pages (from-to)1117-1119
    Number of pages3
    JournalNature Medicine
    Volume16
    Issue number10
    DOIs
    StatePublished - Oct 2010

    Fingerprint

    Viremia
    Macaca
    Neutralizing Antibodies
    B-Lymphocytes
    Cells
    Disease control
    HIV-1
    Immunoglobulin G
    Mothers
    HIV
    Newborn Infant
    Plasmas
    Antibodies
    Infection

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)
    • Medicine(all)

    Cite this

    Ng, C. T., Jaworski, J. P., Jayaraman, P., Sutton, W. F., Delio, P., Kuller, L., ... Haigwood, N. (2010). Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nature Medicine, 16(10), 1117-1119. https://doi.org/10.1038/nm.2233

    Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. / Ng, Cherie T.; Jaworski, J. Pablo; Jayaraman, Pushpa; Sutton, William F.; Delio, Patrick; Kuller, Larene; Anderson, David; Landucci, Gary; Richardson, Barbra A.; Burton, Dennis R.; Forthal, Donald N.; Haigwood, Nancy.

    In: Nature Medicine, Vol. 16, No. 10, 10.2010, p. 1117-1119.

    Research output: Contribution to journalArticle

    Ng, CT, Jaworski, JP, Jayaraman, P, Sutton, WF, Delio, P, Kuller, L, Anderson, D, Landucci, G, Richardson, BA, Burton, DR, Forthal, DN & Haigwood, N 2010, 'Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques', Nature Medicine, vol. 16, no. 10, pp. 1117-1119. https://doi.org/10.1038/nm.2233
    Ng CT, Jaworski JP, Jayaraman P, Sutton WF, Delio P, Kuller L et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nature Medicine. 2010 Oct;16(10):1117-1119. https://doi.org/10.1038/nm.2233
    Ng, Cherie T. ; Jaworski, J. Pablo ; Jayaraman, Pushpa ; Sutton, William F. ; Delio, Patrick ; Kuller, Larene ; Anderson, David ; Landucci, Gary ; Richardson, Barbra A. ; Burton, Dennis R. ; Forthal, Donald N. ; Haigwood, Nancy. / Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. In: Nature Medicine. 2010 ; Vol. 16, No. 10. pp. 1117-1119.
    @article{8b1e5c4498584994a6627d0dc9612a44,
    title = "Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques",
    abstract = "Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.",
    author = "Ng, {Cherie T.} and Jaworski, {J. Pablo} and Pushpa Jayaraman and Sutton, {William F.} and Patrick Delio and Larene Kuller and David Anderson and Gary Landucci and Richardson, {Barbra A.} and Burton, {Dennis R.} and Forthal, {Donald N.} and Nancy Haigwood",
    year = "2010",
    month = "10",
    doi = "10.1038/nm.2233",
    language = "English (US)",
    volume = "16",
    pages = "1117--1119",
    journal = "Nature Medicine",
    issn = "1078-8956",
    publisher = "Nature Publishing Group",
    number = "10",

    }

    TY - JOUR

    T1 - Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

    AU - Ng, Cherie T.

    AU - Jaworski, J. Pablo

    AU - Jayaraman, Pushpa

    AU - Sutton, William F.

    AU - Delio, Patrick

    AU - Kuller, Larene

    AU - Anderson, David

    AU - Landucci, Gary

    AU - Richardson, Barbra A.

    AU - Burton, Dennis R.

    AU - Forthal, Donald N.

    AU - Haigwood, Nancy

    PY - 2010/10

    Y1 - 2010/10

    N2 - Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.

    AB - Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.

    UR - http://www.scopus.com/inward/record.url?scp=77957820631&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77957820631&partnerID=8YFLogxK

    U2 - 10.1038/nm.2233

    DO - 10.1038/nm.2233

    M3 - Article

    C2 - 20890292

    AN - SCOPUS:77957820631

    VL - 16

    SP - 1117

    EP - 1119

    JO - Nature Medicine

    JF - Nature Medicine

    SN - 1078-8956

    IS - 10

    ER -